Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $14.99M.
ENTERPRISE VALUE (EV)
$14.99M
Aligos Therapeutics, Inc.
Market Cap
$33.29M
Enterprise Value (EV)
$14.99M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.29M | $14.99M |
| Scilex Holding Company (SCLX)vs › | $33.29M | $128.28M |
| Accuray Incorporated (ARAY)vs › | $33.11M | $176.36M |
| HeartBeam, Inc. (BEAT)vs › | $34.05M | $25.33M |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | $20.66M |
| Elutia Inc (ELUT)vs › | $34.70M | $25.60M |
| Rockwell Medical, Inc. (RMTI)vs › | $31.86M | $35.27M |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.50M | $45.43M |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | $47.95M |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.19M | $28.31M |
Market Cap
$33.29M
Total Debt
$0.00
Cash
$18.30M
Enterprise Value
$14.99M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
